Lilly expands specialty portfolio in India

New Delhi: US firm Eli Lilly is deepening its specialty portfolio in India across cardio metabolic health, oncology, neurology and immunology, with the launch of its Alzheimer’s therapy. The company has strategic partnerships with domestic drugmakers Lupin and Cipla in diabetes and metabolic care, and […]